In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates

被引：45
|
作者：
Kim, Dae Hun [1 ]
Jhun, Byung Woo [1 ]
Moon, Seong Mi [1 ]
Kim, Su-Young [1 ]
Jeon, Kyeongman [1 ]
Kwon, O. Jung [1 ]
Huh, Hee Jae [2 ]
Lee, Nam Yong [2 ]
Shin, Sung Jae [3 ,4 ,5 ]
Daley, Charles L. [6 ,7 ]
Koh, Won-Jung [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med,Samsung Med Ctr, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Lab Med & Genet, Samsung Med Ctr, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, Seoul, South Korea
[6] Natl Jewish Hlth, Div Mycobacterial & Resp Infect, Denver, CO USA
[7] Univ Colorado, Dept Med, Aurora, CO USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2019年 / 63卷 / 08期
基金：
新加坡国家研究基金会;
关键词：
Mycobacterium abscessus; Mycobacterium avium complex; Mycobacteriurn kansasii; bedaquiline; delamanid; nontuberculous mycobacteria; TREATMENT OUTCOMES; PULMONARY-DISEASE; DIAGNOSIS; EMERGENCE; MECHANISM; DRUG;
D O I：
10.1128/AAC.00665-19
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We evaluated the in vitro activities of the antimicrobial drugs bedaquiline and delamanid against the major pathogenic nontuberculous mycobacteria (NTM). Delamanid showed high MIC values for all NTM except Mycobacterium kansasii. However, bedaquiline showed low MIC values for the major pathogenic NTM, including Mycobacterium avium complex, Mycobacterium abscessus subsp. abscessus, M. abscessus subsp. massiliense, and M. kansasii. Bedaquiline also had low MIC values with macrolide-resistant NTM strains and warrants further investigation as a potential antibiotic for NTM treatment.
引用
收藏
页数：6
相关论文
共 50 条
  • [1] In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates
    Kim, Dae Hun
    Kim, Su-Young
    Koh, Won-Jung
    Jhun, Byung Woo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (07)
  • [2] In Vitro Activity of Rifamycin Derivatives against Nontuberculous Mycobacteria, Including Macrolide- and Amikacin-Resistant Clinical Isolates
    Kim, Dae Hun
    Kim, Su-Young
    Huh, Hee Jae
    Lee, Nam Yong
    Koh, Won-Jung
    Jhun, Byung Woo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (05)
  • [3] In Vitro Activities of Bedaquiline and Delamanid against Nontuberculous Mycobacteria Isolated in Beijing, China
    Yu, Xia
    Gao, XiaoPan
    Li, Chenghai
    Luo, Jingjing
    Wen, Shuan
    Zhang, Tingting
    Ma, Yifeng
    Dong, Lingling
    Wang, Fen
    Huang, Hairong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
  • [4] In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China
    Pang, Yu
    Zheng, Huiwen
    Tan, Yaoju
    Song, Yuanyuan
    Zhao, Yanlin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (05)
  • [5] In vitro activity of bedaquiline against rapidly growing nontuberculous mycobacteria
    Aguilar-Ayala, Diana A.
    Cnockaert, Margo
    Andre, Emmanuel
    Andries, Koen
    Gonzalez-Y-Merchand, Jorge A.
    Vandamme, Peter
    Carlos Palomino, Juan
    Martin, Anandi
    JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (08) : 1140 - 1143
  • [6] In vitro activity of bedaquiline against slow-growing nontuberculous mycobacteria
    Martin, Anandi
    Godino, Isabel Torres
    Angelica Aguilar-Ayala, Diana
    Mathys, Vanessa
    Lounis, Nacer
    Villalobos, Hector Rodriguez
    JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (08) : 1137 - 1139
  • [7] In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States
    Green, M
    Allen, C
    Bradley, J
    Dashefsky, B
    Gilsdorf, JR
    Marcon, MJ
    Schutze, GE
    Smith, C
    Walter, E
    Martin, JM
    Edwards, KA
    Barbadora, KA
    Rumbaugh, RM
    Wald, ER
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) : 2487 - 2489
  • [8] Disposition of oral telithromycin in foals and in vitro activity of the drug against macrolide-susceptible and macrolide-resistant Rhodococcus equi isolates
    Javsicas, L. H.
    Giguere, S.
    Womble, Ariel Y.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2010, 33 (04) : 383 - 388
  • [9] In vitro activities of 19 antimicrobial agents against macrolide-resistant Campylobacter jejuni isolates
    Hakanen, A. J.
    Lehtopolku, M.
    Nakari, U. -M.
    Kotilainen, P.
    Haanpera, M.
    Jalava, J.
    Huovinen, P.
    Siitonen, A.
    Hakanen, A. J.
    ZOONOSES AND PUBLIC HEALTH, 2007, 54 : 114 - 115
  • [10] In vitro activity of gepotidacin and comparator antimicrobials against isolates of nontuberculous mycobacteria (NTM)
    Brown-Elliott, Barbara A.
    Bush, Georgie
    Hughes, M. Dolores
    Rodriguez, Eliana
    Weikel, Chase A.
    Min, Sharon B.
    Wallace Jr, Richard J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (06)
12345